Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
J Neurosci Res ; 59(1): 126-35, 2000 Jan 01.
Article in English | MEDLINE | ID: mdl-10658193

ABSTRACT

Acute doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) elicited degenerative and apparently compensatory changes in the nigrostriatum of injected animals within 1 day of treatment. In the substantia nigra pars compacta (SNc), low-dose (20 mg/kg) administration elicited early degeneration of mitochondria in the absence of other effects. In the striatum, a low MPTP dose resulted in myelin unwinding, demyelination, cytoplasmic shrinkage, and disturbance of synaptic communication, as evinced by a profound reduction in synaptic vesicle production. High-dose (40 mg/kg) administration generated more drastic axonal degeneration leading to cell elimination in the striatum. At neither dose was mitochondrial disturbance evident in the striatum. Evidence is presented that darkened synaptic boutons, visible at this level of MPTP administration, were part of healthy enlarged axons with an elevated number of synaptic contacts. These spared neuronal processes, therefore, were hypothesized to compensate for the MPTP-induced death of dopaminergic neurons by adaptive structural modifications that would serve to enhance their functional capability.


Subject(s)
MPTP Poisoning/pathology , Neostriatum/drug effects , Neostriatum/ultrastructure , Neuronal Plasticity/drug effects , Neurons/drug effects , Neurons/ultrastructure , Substantia Nigra/drug effects , Substantia Nigra/ultrastructure , Animals , Dopamine/metabolism , MPTP Poisoning/metabolism , Male , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission , Neostriatum/metabolism , Neurons/metabolism , Substantia Nigra/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...